BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 125204)

  • 1. Cassaine: mechanism of inhibition of Na+ +K+ -ATPase and relationship of this inhibition to cardiotonic actions.
    Tobin T; Akera T; Brody SL; Ku D; Brody TM
    Eur J Pharmacol; 1975; 32(02):133-45. PubMed ID: 125204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the stable inhibition of Na+ + K+-ATPase by cassaine.
    Tobin T; Akera T; Brody TM; Taneja HR
    Eur J Pharmacol; 1976 Jan; 35(1):59-68. PubMed ID: 130244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of K+ on the interaction between cardiac glycosides and Na,K-ATPase.
    Akera T; Ng YC; Shieh IS; Bero E; Brody TM; Braselton WE
    Eur J Pharmacol; 1985 May; 111(2):147-57. PubMed ID: 2990948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac glycosides: relationship among active 86Rb uptake, (Na+,K+)-ATPase activity, and inotropy in guinea pig heart.
    Akera T; Ku D; Brody TM
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():337-44. PubMed ID: 130662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotonic site directed irreversible inhibition of Na+ + K+-ATPase by 3-azidoacetylstrophanthidin, a photochemical analogue of strophanthidin.
    Tobin T; Akera T; Brody TM; Taneja HR
    Eur J Pharmacol; 1976 Jan; 35(1):69-76. PubMed ID: 130245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a dissociation between positive inotropic effect and inhibition of the Na+-K+-ATPase by ouabain, cassaine and their alkylating derivatives.
    Peters T; Raben RH; Wassermann O
    Eur J Pharmacol; 1974 May; 26(2):166-74. PubMed ID: 4277475
    [No Abstract]   [Full Text] [Related]  

  • 7. High affinity and low affinity ouabain binding sites in the rat heart.
    Akera T; Ng YC; Hadley R; Katano Y; Brody TM
    Eur J Pharmacol; 1986 Dec; 132(2-3):137-46. PubMed ID: 3028836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible inhibition of 3H-ouabain binding to Na+ +K+ -ATPase by digoxigenin-3,12-dibromoacetate, an alkylating derivative of digoxigenin.
    Tobin T; Abramson H
    Eur J Pharmacol; 1975; 32(02):243-50. PubMed ID: 125205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digitalis structure-activity relationship analyses. Conclusions from indirect binding studies with cardiac (Na+ + K+)-ATPase.
    Brown L; Erdmann E; Thomas R
    Biochem Pharmacol; 1983 Sep; 32(18):2767-74. PubMed ID: 6313008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on (Na+ plus K+)-activated ATPase. XXXVII. Stabilization by cations of the enzyme-ouabain complex formed with Mg1+ and inorganic phosphate.
    Schuurmans Stekhoven FM; De Pont JJ; Bonting SL
    Biochim Biophys Acta; 1976 Jan; 419(1):137-49. PubMed ID: 128379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Na+, K+-adenosine triphosphatase inhibition by ouabain and myocardial sodium: a computer simulation.
    Akera T; Bennett RT; Olgaard MK; Brody TM
    J Pharmacol Exp Ther; 1976 Nov; 199(2):287-97. PubMed ID: 135837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone-3, 20-bisguanylhydrazone: Na+, K+-ATPase inhibition and positive inotropic action.
    Yamamoto S; Akera T; Brody TM
    Eur J Pharmacol; 1978 May; 49(2):121-32. PubMed ID: 149010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New aspects on the mode of action of cardiac glycosides].
    Fricke U
    Fortschr Med; 1976 Nov; 94(32):1037-45. PubMed ID: 136410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-associated differences in guinea pig myocardial Na+, K+-ATPase activity and ouabain inhibition and in Mg2+-ATPase activity.
    Kroening BH; Weintraub M
    Pharmacology; 1980; 21(3):193-7. PubMed ID: 6251488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saturable adenosine 5'-triphosphate-independent binding of [3H]-ouabain to brain and cardiac tissue in vitro.
    Akera T; Brody TM; Wiest SA
    Br J Pharmacol; 1979 Mar; 65(3):403-9. PubMed ID: 218666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand effects on membrane lipids associated with sodium, potassium-activated adenosine triphosphatase: comparative spin probe studies with rat brain and heart enzyme preparations.
    Coughlin RT; Akera T; McGroarty EJ; Steinbach C
    Mol Pharmacol; 1987 Jul; 32(1):147-53. PubMed ID: 3037299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Na+,K+-ATPase isoenzymes: sensitivity to prednisolone bisguanylhydrazone.
    Ng YC; Leung WY; Akera T
    Eur J Pharmacol; 1988 Oct; 155(1-2):93-9. PubMed ID: 2854075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for two different Na+-dependent [3H]-ouabain binding sites of a Na+-K+-ATPase of guinea-pig hearts.
    Fricke U; Klaus W
    Br J Pharmacol; 1977 Nov; 61(3):423-8. PubMed ID: 145257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.